 |
Previous Article | Next Article 
Uncoupling of Myelin Assembly and Schwann Cell Differentiation by
Transgenic Overexpression of Peripheral Myelin Protein 22
Stephan
Niemann1,
Michael W.
Sereda1,
Ueli
Suter2,
Ian R.
Griffiths3, and
Klaus-Armin
Nave1
1 Zentrum für Molekulare Biologie (ZMBH),
University of Heidelberg, D-69120 Heidelberg, Germany,
2 Institute of Cell Biology, Department of Biology, Swiss
Federal Institute of Technology, Eidgenössische Technische
Hochschule-Hoenggerberg, CH-8093 Zürich, Switzerland, and
3 Applied Neurobiology Group, Department of Veterinary
Clinical Studies, University of Glasgow, Glasgow G61 1QH, United
Kingdom
We have generated previously transgenic rats that overexpress
peripheral myelin protein 22 (PMP22) in Schwann cells. In the nerves of
these animals, Schwann cells have segregated with axons to the normal
1:1 ratio but remain arrested at the promyelinating stage, apparently
unable to elaborate myelin sheaths. We have examined gene expression of
these dysmyelinating Schwann cells using semiquantitative reverse
transcription-PCR and immunofluorescence analysis. Unexpectedly,
Schwann cell differentiation appears to proceed normally at the
molecular level when monitored by the expression of mRNAs encoding
major structural proteins of myelin. Furthermore, an aberrant
coexpression of early and late Schwann cell markers was observed. PMP22
itself acquires complex glycosylation, suggesting that trafficking of
the myelin protein through the endoplasmic reticulum is not
significantly impaired. We suggest that PMP22, when overexpressed,
accumulates in a late Golgi-cell membrane compartment and uncouples
myelin assembly from the underlying program of Schwann cell differentiation.
Key words:
transgenic disease model; Charcot-Marie-Tooth neuropathy; myelin disease; axon-Schwann cell interaction; abnormal gene dosage; myelin protein function
Copyright © 2000 Society for Neuroscience 0270-6474/00/20114120-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
L. Nobbio, L. Sturla, F. Fiorese, C. Usai, G. Basile, I. Moreschi, F. Benvenuto, E. Zocchi, A. De Flora, A. Schenone, et al.
P2X7-mediated Increased Intracellular Calcium Causes Functional Derangement in Schwann Cells from Rats with CMT1A Neuropathy
J. Biol. Chem.,
August 21, 2009;
284(34):
23146 - 23158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Chies, L. Nobbio, P. Edomi, A. Schenone, C. Schneider, and C. Brancolini
Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22
J. Cell Sci.,
March 15, 2003;
116(6):
987 - 999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Dickson, J. J. M. Bergeron, I. Shames, J. Colby, D. T. Nguyen, E. Chevet, D. Y. Thomas, and G. J. Snipes
Association of calnexin with mutant peripheral myelin protein-22 ex vivo: A basis for "gain-of-function" ER diseases
PNAS,
July 23, 2002;
99(15):
9852 - 9857.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sancho, P. Young, and U. Suter
Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A
Brain,
November 1, 2001;
124(11):
2177 - 2187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Perea, A. Robertson, T. Tolmachova, J. Muddle, R. H. M. King, S. Ponsford, P. K. Thomas, and C. Huxley
Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A
Hum. Mol. Genet.,
May 1, 2001;
10(10):
1007 - 1018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Schneider, F. Bosse, D. D'Urso, H.-W. Muller, M. W. Sereda, K.-A. Nave, A. Niehaus, T. Kempf, M. Schnolzer, and J. Trotter
The AN2 Protein Is a Novel Marker for the Schwann Cell Lineage Expressed by Immature and Nonmyelinating Schwann Cells
J. Neurosci.,
February 1, 2001;
21(3):
920 - 933.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|